Reversol

Reversol was a pharmaceutical company primarily known for its eponymous product, Reversol (edrophonium chloride), which is used as a diagnostic agent for myasthenia gravis. The company focused on the manufacturing and distribution of specialized injectable medications used in hospital and clinical settings. Reversol (edrophonium) acts as a rapid-onset, short-acting acetylcholinesterase inhibitor, facilitating the Tensilon test to differentiate between myasthenic and cholinergic crises. While the brand name remains associated with the drug, the company's operations have largely been absorbed or discontinued in the modern pharmaceutical market, with the product often being managed by larger entities like Organon or generic manufacturers.